Best practice in the management of benign prostatic hyperplasia in the patients requiring anticoagulation

Joshua Heiman, Tim Large, Amy Krambeck*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


In today’s aging population, urologists are often treating older patients with multiple comorbidities. Lower urinary tract symptoms from benign prostate hyperplasia (LUTS/BPH) is a common condition that affects men, with increasing prevalence as men age. In a subset of patients, the symptoms are too severe or refractory to medical therapy and, therefore, surgical therapy is required to improve their LUTS. The use of medical therapy often delays the need to intervene surgically in men with LUTS/BPH and with advances in the management of cardiovascular disease, urologists are increasingly encountering more men requiring BPH surgery on chronic anticoagulation therapy. The decision of when to offer surgical intervention and how to manage anticoagulation medication in the perioperative setting is a dilemma with which surgeons are dealing with increasing frequency. The purpose of this review is to clarify the optimal approach to the surgical patient with LUTS/ BPH requiring anticoagulation therapy.

Original languageEnglish (US)
Pages (from-to)431-436
Number of pages6
JournalTherapeutic Advances in Urology
Issue number12
StatePublished - Dec 1 2018


  • anthiplatelet thrapy
  • anticoagulation therapy
  • benign prostate hyperplasia (BPH)
  • lower urinary tract symptoms (LUTS)
  • surgical interventions

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Best practice in the management of benign prostatic hyperplasia in the patients requiring anticoagulation'. Together they form a unique fingerprint.

Cite this